FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1987001896> ?p ?o ?g. }

• W1987001896 endingPage "19.e2" @default.
• W1987001896 startingPage "9" @default.
• W1987001896 abstract "To determine the incidence and progression of macular atrophy in patients with neovascular age-related macular degeneration (AMD) treated with vascular endothelial growth factor (VEGF) antagonists.Retrospective interventional case series.All patients with neovascular AMD treated by the same physician during a 12-month period of ascertainment had all images from their entire follow-up period evaluated, and areas of retina that developed atrophy were compared to the same areas prior to the onset of anti-VEGF treatment. Longitudinal measurements of retinal atrophy were made.In 39 patients, 52 eyes with neovascular AMD were identified. We excluded 5 eyes from analysis (4 had retinal pigment epithelium tears, and 1 had a laser scar). Fundus photographs of the remaining eyes showed that 18/47 eyes (38%) contained hypopigmented areas suggestive of atrophy within the macula at some time during follow-up. Spectral-domain optical coherence tomography confirmed that these areas had loss of retinal pigmented epithelium and ellipsoids zones, with or without subretinal material suggestive of subretinal fibrosis. Comparison of fundus photographs with fluorescein angiograms showed that in 13/18 eyes (72%), atrophy developed in areas previously occupied by choroidal neovascularization, and the other 5 eyes had atrophy prior to the onset of anti-VEGF treatment. The mean (± standard deviation) rate of increase in pure atrophic areas (no subretinal material) was 0.7 ± 0.8 mm(2) per year, with a range of 0.01-2.6 mm(2)/year.Treatment of neovascular AMD with a VEGF-neutralizing protein can result in regression of choroidal neovascularization, which is sometimes associated with atrophy of overlying retina." @default.
• W1987001896 created "2016-06-24" @default.
• W1987001896 creator A5004807592 @default.
• W1987001896 creator A5009464457 @default.
• W1987001896 creator A5019942404 @default.
• W1987001896 creator A5036363062 @default.
• W1987001896 creator A5065304127 @default.
• W1987001896 creator A5082745210 @default.
• W1987001896 creator A5083222735 @default.
• W1987001896 creator A5085965174 @default.
• W1987001896 creator A5088380787 @default.
• W1987001896 creator A5089627225 @default.
• W1987001896 date "2015-01-01" @default.
• W1987001896 modified "2023-10-18" @default.
• W1987001896 title "Regression of Choroidal Neovascularization Results in Macular Atrophy in Anti-Vascular Endothelial Growth Factor-Treated Eyes" @default.
• W1987001896 cites W1481978003 @default.
• W1987001896 cites W1500728559 @default.
• W1987001896 cites W1541005345 @default.
• W1987001896 cites W1546928690 @default.
• W1987001896 cites W1970714860 @default.
• W1987001896 cites W1972999199 @default.
• W1987001896 cites W1981604301 @default.
• W1987001896 cites W2004117352 @default.
• W1987001896 cites W2031202579 @default.
• W1987001896 cites W2048957921 @default.
• W1987001896 cites W2054857117 @default.
• W1987001896 cites W2058344658 @default.
• W1987001896 cites W2060651294 @default.
• W1987001896 cites W2085712747 @default.
• W1987001896 cites W2098155102 @default.
• W1987001896 cites W2124415048 @default.
• W1987001896 cites W2131192872 @default.
• W1987001896 cites W2401288801 @default.
• W1987001896 cites W2598520882 @default.
• W1987001896 doi "https://doi.org/10.1016/j.ajo.2014.09.012" @default.
• W1987001896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25217857" @default.
• W1987001896 hasPublicationYear "2015" @default.
• W1987001896 type Work @default.
• W1987001896 sameAs 1987001896 @default.
• W1987001896 citedByCount "39" @default.
• W1987001896 countsByYear W19870018962015 @default.
• W1987001896 countsByYear W19870018962016 @default.
• W1987001896 countsByYear W19870018962017 @default.
• W1987001896 countsByYear W19870018962018 @default.
• W1987001896 countsByYear W19870018962019 @default.
• W1987001896 countsByYear W19870018962020 @default.
• W1987001896 countsByYear W19870018962021 @default.
• W1987001896 countsByYear W19870018962022 @default.
• W1987001896 crossrefType "journal-article" @default.
• W1987001896 hasAuthorship W1987001896A5004807592 @default.
• W1987001896 hasAuthorship W1987001896A5009464457 @default.
• W1987001896 hasAuthorship W1987001896A5019942404 @default.
• W1987001896 hasAuthorship W1987001896A5036363062 @default.
• W1987001896 hasAuthorship W1987001896A5065304127 @default.
• W1987001896 hasAuthorship W1987001896A5082745210 @default.
• W1987001896 hasAuthorship W1987001896A5083222735 @default.
• W1987001896 hasAuthorship W1987001896A5085965174 @default.
• W1987001896 hasAuthorship W1987001896A5088380787 @default.
• W1987001896 hasAuthorship W1987001896A5089627225 @default.
• W1987001896 hasBestOaLocation W19870018962 @default.
• W1987001896 hasConcept C118487528 @default.
• W1987001896 hasConcept C126322002 @default.
• W1987001896 hasConcept C141071460 @default.
• W1987001896 hasConcept C142724271 @default.
• W1987001896 hasConcept C169760540 @default.
• W1987001896 hasConcept C2776391266 @default.
• W1987001896 hasConcept C2776403814 @default.
• W1987001896 hasConcept C2776694085 @default.
• W1987001896 hasConcept C2777093970 @default.
• W1987001896 hasConcept C2777802072 @default.
• W1987001896 hasConcept C2778024200 @default.
• W1987001896 hasConcept C2778271429 @default.
• W1987001896 hasConcept C2780248432 @default.
• W1987001896 hasConcept C2780394083 @default.
• W1987001896 hasConcept C2780827179 @default.
• W1987001896 hasConcept C2781100027 @default.
• W1987001896 hasConcept C2781172350 @default.
• W1987001896 hasConcept C2781359195 @default.
• W1987001896 hasConcept C71924100 @default.
• W1987001896 hasConcept C86803240 @default.
• W1987001896 hasConceptScore W1987001896C118487528 @default.
• W1987001896 hasConceptScore W1987001896C126322002 @default.
• W1987001896 hasConceptScore W1987001896C141071460 @default.
• W1987001896 hasConceptScore W1987001896C142724271 @default.
• W1987001896 hasConceptScore W1987001896C169760540 @default.
• W1987001896 hasConceptScore W1987001896C2776391266 @default.
• W1987001896 hasConceptScore W1987001896C2776403814 @default.
• W1987001896 hasConceptScore W1987001896C2776694085 @default.
• W1987001896 hasConceptScore W1987001896C2777093970 @default.
• W1987001896 hasConceptScore W1987001896C2777802072 @default.
• W1987001896 hasConceptScore W1987001896C2778024200 @default.
• W1987001896 hasConceptScore W1987001896C2778271429 @default.
• W1987001896 hasConceptScore W1987001896C2780248432 @default.
• W1987001896 hasConceptScore W1987001896C2780394083 @default.
• W1987001896 hasConceptScore W1987001896C2780827179 @default.
• W1987001896 hasConceptScore W1987001896C2781100027 @default.
• W1987001896 hasConceptScore W1987001896C2781172350 @default.
• W1987001896 hasConceptScore W1987001896C2781359195 @default.

• next